The role of protein O-linked β-N-acetylglucosamine in mediating cardiac stress responses

Biochimica et Biophysica Acta - General Subjects

Volumn 1800, Issue 2, 2010, Pages 57-66

  Chatham, John C ^a,b   Marchase, Richard B ^b  

^a Center for Free Radical Biology   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Capacitative calcium entry (CCE); Hexosamine biosynthesis; O GlcNAc transferase; Orai1; Protein O glycosylation; STIM1

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; GLUTAMINE; HEAT SHOCK PROTEIN 70; HEXOSAMINE; MEMBRANE PROTEIN; N ACETYLGLUCOSAMINE; STROMAL INTERACTION MOLECULE 1; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

AEROBIC METABOLISM; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL SURVIVAL; GLUCOSE METABOLISM; HEART INFARCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART PROTECTION; HUMAN; HYPERGLYCEMIA; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REPERFUSION INJURY; REVIEW; TRANSCRIPTION REGULATION;

ACETYLGLUCOSAMINE; ANIMALS; CALCIUM; CALCIUM CHANNELS; CARDIOTONIC AGENTS; GLUCOSE; GLUTAMINE; HEXOSAMINES; HOMEOSTASIS; HUMANS; MEMBRANE PROTEINS; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; NEOPLASM PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; STRESS, PHYSIOLOGICAL;

EID: 77949340941     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.07.004     Document Type: Review

References (144)

1. Torres C.R., and Hart G.W. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J. Biol. Chem. 259 (1984) 3308-3317
2. Slawson C., Housley M.P., and Hart G.W. O-GlcNAc cycling: How a single sugar post-translational modification is changing the way we think about signaling networks. J. Cell Biochem. 97 (2006) 71-83
3. Zachara N.E., and Hart G.W. O-GlcNAc a sensor of cellular state: The role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim. Biophys. Acta. 1673 (2004) 13-28
4. Zachara N.E., and Hart G.W. Cell signaling, the essential role of O-GlcNAc!. Biochim. Biophys. Acta. 1761 (2006) 599-617
5. Love D.C., and Hanover J.A. The hexosamine signaling pathway: Deciphering the "O-GlcNAc code". Sci. STKE. 2005 (2005) re13
6. Hart G.W. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu. Rev. Biochem. 66 (1997) 315-335
7. Dehennaut V., Lefebvre T., Sellier C., Leroy Y., Gross B., Walker S., Cacan R., Michalski J.C., Vilain J.P., and Bodart J.F. O-linked N-acetylglucosaminyltransferase inhibition prevents G2/M transition in Xenopus laevis oocytes. J. Biol. Chem. 282 (2007) 12527-12536
8. Guinez C., Morelle W., Michalski J.C., and Lefebvre T. O-GlcNAc glycosylation: A signal for the nuclear transport of cytosolic proteins?. Int. J. Biochem. Cell Biol. 37 (2005) 765-774
9. Wells L., Whalen S.A., and Hart G.W. O-GlcNAc: A regulatory post-translational modification. Biochem. Biophys. Res. Commun. 302 (2003) 435-441
10. Liu K., Paterson A.J., Zhang F., McAndrew J., Fukuchi K., Wyss J.M., Peng L., Hu Y., and Kudlow J.E. Accumulation of protein O-GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O-GlcNAc metabolism. J. Neurochem. 89 (2004) 1044-1055
11. Comer F.I., and Hart G.W. O-GlcNAc and the control of gene expression. Biochim. Biophys. Acta. 1473 (1999) 161-171
12. Zachara N.E., and Hart G.W. O-GlcNAc modification: A nutritional sensor that modulates proteasome function. Trends. Cell Biol. 14 (2004) 218-221
13. Han I., and Kudlow J.E. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell Biol. 17 (1997) 2550-2558
14. Fulop N., Mason M.M., Dutta K., Wang P., Davidoff A.J., Marchase R.B., and Chatham J.C. The impact of Type-2 diabetes and aging on cardiomyocyte function and O-Linked N-acetylglucosamine levels in the heart. Am. J. Physiol. Cell Physiol. 292 (2007) C1370-C1378
15. Rex-Mathes M., Werner S., Strutas D., Griffith L.S., Viebahn C., Thelen K., and Schmitz B. O-GlcNAc expression in developing and ageing mouse brain. Biochimie 83 (2001) 583-590
16. Fulop N., Feng W., Xing D., He K., Not L.G., Brocks C.A., Marchase R.B., Miller A.P., and Chatham J.C. Aging leads to increased levels of protein O-linked N-acetylglucosamine in heart, aorta, brain and skeletal muscle in Brown-Norway rats. Biogerontology 9 (2008) 139-151
17. Chou T.Y., Hart G.W., and Dang C.V. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J. Biol. Chem. 270 (1995) 18961-18965
18. Shaw P., Freeman J., Bovey R., and Iggo R. Regulation of specific DNA binding by p53: Evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene 12 (1996) 921-930
19. Donadio A.C., Lobo C., Tosina M., de la Rosa V., Martin-Rufian M., Campos-Sandoval J.A., Mates J.M., Marquez J., Alonso F.J., and Segura J.A. Antisense glutaminase inhibition modifies the O-GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells. J. Cell Biochem. 103 (2008) 800-811
20. Hanover J.A. Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J. 15 (2001) 1865-1876
21. Dias W.B., and Hart G.W. O-GlcNAc modification in diabetes and Alzheimer's disease. Mol. Biosyst. 3 (2007) 766-772
22. Buse M.G. Hexosamines, insulin resistance, and the complications of diabetes: Current status. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E1-E8
23. Copeland R.J., Bullen J.W., and Hart G.W. Cross-talk between GlcNAcylation and phosphorylation: Roles in insulin resistance and glucose toxicity. Am. J. Physiol. Endocrinol. Metab. 295 (2008) E17-28
24. Lubas W.A., Frank D.W., Krause M., and Hanover J.A. O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J. Biol. Chem. 272 (1997) 9316-9324
25. Shafi R., Iyer S.P., Ellies L.G., O'Donnell N., Marek K.W., Chui D., Hart G.W., and Marth J.D. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 5735-5739
26. Ljungqvist O., Boija P.O., and Ware J. The effect of hyperosmolar infusions on survival after hemorrhage. Acta. Chir. Scand. 155 (1989) 433-438
27. Alibegovic A., and Ljungqvist O. Pretreatment with glucose infusion prevents fatal outcome after hemorrhage in food deprived rats. Circ. Shock. 39 (1993) 1-6
28. Ljungqvist O., and Alibegovic A. Hyperglycaemia and survival after haemorrhage. Eur. J. Surg. 160 (1994) 465-469
29. Nettelbladt C.G., Alibergovic A., and Ljungqvist O. Pre-stress carbohydrate solution prevents fatal outcome after hemorrhage in 24-hour food-deprived rats. Nutrition 12 (1996) 696-699
30. Svedjeholm R., Hakanson E., and Vanhanen I. Rationale for metabolic support with amino acids and glucose-insulin-potassium (GIK) in cardiac surgery. Ann. Thorac. Surg. 59 (1995) S15-S22
31. Schipke J.D., Friebe R., and Gams E. Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: A review of randomized, controlled trials. Eur. J. Cardiothorac. Surg. 29 (2006) 479-485
32. Hamdulay S.S., Al-Khafaji A., and Montgomery H. Glucose-insulin and potassium infusions in septic shock. Chest 129 (2006) 800-804
33. Fang R.H., Chen J.S., Lin J.T., King Y.H., and Kuo J.S. A modified formula of GIK (glucose-insulin-potassium) therapy for treatment of extensive burn injury in dogs. J. Trauma 29 (1989) 344-349
34. Stremple J.E., Thomas H., Sakach V., and Trelka D. Myocardial utilization of hypertonic glucose during hemorrhagic shock. Surgery 80 (1976) 4-13
35. Fath-Ordoubadi F., and Beatt K.J. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: An overview of randomized placebo-controlled trials. Circulation 96 (1997) 1152-1156
36. Jarhult J. Osmotic fluid transfer from tissue to blood during hemorrhagic hypotension. Acta. Physiol. Scand. 89 (1973) 213-226
37. Stone J.P., Schutzer S.F., McCoy S., and Drucker W.R. Contribution of glucose to the hyperosmolality of prolonged hypovolemia. Am. Surg. 43 (1977) 1-5
38. Menguy R., and Masters Y.F. Influence of hyperglycemia on survival after hemorrhagic shock. Adv. Shock. Res. 1 (1978) 43-54
39. Friedman S.G., Pearce F.J., and Drucker W.R. The role of blood glucose in defense of plasma volume during hemorrhage. J. Trauma. 22 (1982) 86-91
40. Ware J., Ljungqvist O., Norberg K.A., and Nylander G. Osmolar changes in haemorrhage: The effects of an altered nutritional status. Acta. Chir. Scand. 148 (1982) 641-646
41. Mizock B.A. Alterations in fuel metabolism in critical illness: Hyperglycaemia. Best Pract. Res. Clin. Endocrinol. Metab. 15 (2001) 533-551
42. Mechanick J.I. Metabolic mechanisms of stress hyperglycemia. JPEN J. Parenter. Enteral. Nutr. 30 (2006) 157-163
43. Sodi-Pallares D., Testelli M., and Fishleder F. Effects of intravenous infusion of a potassium-insulin-glucose solution on the electrographic signs of myocardial infarction. Am. J. Cardiol. 9 (1962) 166-181
44. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 2 (1988) 349-360
45. Schwartz G.G., Olsson A.G., Ezekowitz M.D., Ganz P., Oliver M.F., Waters D., Zeiher A., Chaitman B.R., Leslie S., and Stern T. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial. JAMA 285 (2001) 1711-1718
46. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet 343 (1994) 1115-1122
47. Ranasinghe A.M., McCabe C.J., Quinn D.W., James S.R., Pagano D., Franklyn J.A., and Bonser R.S. How does glucose insulin potassium improve hemodynamic performance? Evidence for altered expression of beta-adrenoreceptor and calcium handling genes. Circulation 114 (2006) I239-I244
48. Ranasinghe A.M., Quinn D.W., Pagano D., Edwards N., Faroqui M., Graham T.R., Keogh B.E., Mascaro J., Riddington D.W., Rooney S.J., Townend J.N., Wilson I.C., and Bonser R.S. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting. Circulation 114 (2006) I245-250
49. Leos C.L., Griego J.E., and Anderson J.R. Glucose-insulin-potassium therapy in the era of coronary revascularization. Cardiol. Rev. 13 (2005) 266-270
50. Stanley Jr. A.W., Moraski R.E., Russell R.O., Rogers W.J., Mantle J.A., Kreisberg R.A., McDaniel H.G., and Rackley C.E. Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease. Am. J. Cardiol. 36 (1975) 929-937
51. Christian T.F., O'Connor M.K., Schwartz R.S., Gibbons R.J., and Ritman E.L. Technetium-99m MIBI to assess coronary collateral flow during acute myocardial infarction in two closed-chest animal models. J. Nucl. Med. 38 (1997) 1840-1846
52. Sabia P.J., Powers E.R., Ragosta M., Sarembock I.J., Burwell L.R., and Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N. Engl. J. Med. 327 (1992) 1825-1831
53. Lloyd S.G., Wang P.P., Zeng H., and Chatham J.C. The impact of low flow ischemia on substrate oxidation and glycolysis in the isolated perfused rat heart. Am. J. Physiol. Heart. Circ. Physiol. 287 (2004) 351-362
54. Lloyd S., Brocks C., and Chatham J.C. Differential modulation of glucose, lactate and pyruvate oxidation by insulin and dichloroacetate in the isolated perfused rat heart. Am. J. Physiol. Heart. Circ. Physiol. 285 (2003) H163-H172
55. Wang P., Lloyd S.G., and Chatham J.C. The impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery following low flow ischemia. Circulation 111 (2005) 2066-2072
56. Khogali S.E., Harper A.A., Lyall J.A., and Rennie M.J. Effects of l-glutamine on post-ischaemic cardiac function: Protection and rescue. J. Mol. Cell Cardiol. 30 (1998) 819-827
57. Khogali S.E., Pringle S.D., Weryk B.V., and Rennie M.J. Is glutamine beneficial in ischemic heart disease?. Nutrition 18 (2002) 123-126
58. Wischmeyer P.E. The glutamine story: Where are we now?. Curr. Opin. Crit. Care. 12 (2006) 142-148
59. Wischmeyer P.E. Clinical applications of l-glutamine: Past, present, and future. Nutr. Clin. Pract. 18 (2003) 377-385
60. Singleton K.D., and Wischmeyer P.E. Oral glutamine enhances heat shock protein expression and improves survival following hyperthermia. Shock 25 (2006) 295-299
61. Singleton K.D., Beckey V.E., and Wischmeyer P.E. Glutamine prevents activation of NF-κB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock 24 (2005) 583-589
62. Singleton K.D., and Wischmeyer P.E. Glutamine's protection against sepsis and lung injury is dependent on heat shock protein 70 expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2007)
63. Rossetti L., Hawkins M., Chen W., Gindi J., and Barzilai N. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. J. Clin. Invest. 96 (1995) 132-140
64. Wells L., Vosseller K., and Hart G.W. Glycosylation of nucleocytoplasmic proteins: Signal transduction and O-GlcNAc. Science 291 (2001) 2376-2378
65. Wu G., Haynes T.E., Li H., Yan W., and Meininger C.J. Glutamine metabolism to glucosamine is necessary for glutamine inhibition of endothelial nitric oxide synthesis. Biochem. J. 353 (2001) 245-252
66. Haltiwanger R.S., Blomberg M.A., and Hart G.W. Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase. J. Biol. Chem. 267 (1992) 9005-9013
67. Kreppel L.K., and Hart G.W. Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. J. Biol. Chem. 274 (1999) 32015-32022
68. Whelan S.A., Lane M.D., and Hart G.W. Regulation of the O-linked beta-N-acetylglucosamine transferase by insulin signaling. J. Biol. Chem. 283 (2008) 21411-21417
69. Champattanachai V., Marchase R.B., and Chatham J.C. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc. Am. J. Physiol. Cell Physiol. 292 (2007) C178-C187
70. Liu J., Marchase R.B., and Chatham J.C. Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels. J. Mol. Cell Cardiol. 42 (2007) 177-185
71. Zachara N.E., O'Donnell N., Cheung W.D., Mercer J.J., Marth J.D., and Hart G.W. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J. Biol. Chem. 279 (2004) 30133-30142
72. Sohn K.C., Lee K.Y., Park J.E., and Do S.I. OGT functions as a catalytic chaperone under heat stress response: A unique defense role of OGT in hyperthermia. Biochem. Biophys. Res. Commun. 322 (2004) 1045-1051
73. Marshall S., Nadeau O., and Yamasaki K. Dynamic actions of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes: Differential effects on glucosamine 6-phosphate, UDP-N-acetylglucosamine, and ATP levels. J. Biol. Chem. 279 (2004) 35313-35319
74. Liu J., Pang Y., Chang T., Bounelis P., Chatham J.C., and Marchase R.B. Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia. J. Mol. Cell Cardiol. 40 (2006) 303-312
75. Zimmerman A.N., and Hulsmann W.C. Paradoxical influence of calcium ions on the permeability of the cell membranes of the isolated rat heart. Nature 211 (1966) 646-647
76. Konrad R.J., Zhang F., Hale J.E., Knierman M.D., Becker G.W., and Kudlow J.E. Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem. Biophys. Res. Commun. 293 (2002) 207-212
77. Tiedge M., Richter T., and Lenzen S. Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase. Arch. Biochem. Biophys. 375 (2000) 251-260
78. Haltiwanger R.S., Grove K., and Philipsberg G.A. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate. J. Biol. Chem. 273 (1998) 3611-3617
79. Shanmugasundaram B., Debowski A.W., Dennis R.J., Davies G.J., Vocadlo D.J., and Vasella A. Inhibition of O-GlcNAcase by a gluco-configured nagstatin and a PUGNAc-imidazole hybrid inhibitor. Chem. Commun. (Camb). (2006) 4372-4374
80. Bolli R., Becker L., Gross G., Mentzer Jr. R., Balshaw D., and Lathrop D.A. Myocardial protection at a crossroads: The need for translation into clinical therapy. Circ. Res. 95 (2004) 125-134
81. Liu J., Marchase R.B., and Chatham J.C. Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H1391-1399
82. Yang S., Zou L.Y., Bounelis P., Chaudry I., Chatham J.C., and Marchase R.B. Glucosamine administration during resuscitation improves organ function after trauma hemorrhage. Shock 25 (2006) 600-607
83. Zou L.Y., Yang S., Chaudry I.H., Marchase R.B., and Chatham J.C. PUGNAc administration during resuscitation improves organ function following trauma-hemorrhage. Shock 27 (2007) 402-408
84. Jones S.P., Zachara N.E., Ngoh G.A., Hill B.G., Teshima Y., Bhatnagar A., Hart G.W., and Marban E. Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation 117 (2008) 1172-1182
85. Masson E., Wiernsperger N., Lagarde M., and El Bawab S. Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: Implication of gangliosides. Biochem. J. 388 (2005) 537-544
86. Stanley P. A method to the madness of N-glycan complexity?. Cell 129 (2007) 27-29
87. Horsch M., Hoesch L., Vasella A., and Rast D.M. N-acetylglucosaminono-1,5-lactone oxime and the corresponding (phenylcarbamoyl)oxime. Novel and potent inhibitors of beta-N-acetylglucosaminidase. Eur. J. Biochem. 197 (1991) 815-818
88. Perreira M., Kim E.J., Thomas C.J., and Hanover J.A. Inhibition of O-GlcNAcase by PUGNAc is dependent upon the oxime stereochemistry. Bioorg. Med. Chem. 14 (2006) 837-846
89. Macauley M.S., Whitworth G.E., Debowski A.W., Chin D., and Vocadlo D.J. O-GlcNAcase uses substrate-assisted catalysis: Kinetic analysis and development of highly selective mechanism-inspired inhibitors. J. Biol. Chem. 280 (2005) 25313-25322
90. Champattanachai V., Marchase R.B., and Chatham J.C. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am. J. Physiol. Cell Physiol. 294 (2008) C1509-C1520
91. Ngoh G.A., Watson L.J., Facundo H.T., Dillmann W., and Jones S.P. Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition. J. Mol. Cell Cardiol. 45 (2008) 313-325
92. Ngoh G.A., Facundo H.T., Hamid T., Dillmann W., Zachara N.E., and Jones S.P. Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury. Circ. Res. 104 (2009) 41-49
93. Du X.L., Edelstein D., Rossetti L., Fantus I.G., Goldberg H., Ziyadeh F., Wu J., and Brownlee M. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 12222-12226
94. Majumdar G., Wright J., Markowitz P., Martinez-Hernandez A., Raghow R., and Solomon S.S. Insulin stimulates and diabetes inhibits O-linked N-acetylglucosamine transferase and O-glycosylation of Sp1. Diabetes 53 (2004) 3184-3192
95. Lim K.H., and Chang H.I. O-linked N-acetylglucosamine suppresses thermal aggregation of Sp1. FEBS Lett. 580 (2006) 4645-4652
96. Dong L., Wang W., Wang F., Stoner M., Reed J.C., Harigai M., Samudio I., Kladde M.P., Vyhlidal C., and Safe S. Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells. J. Biol. Chem. 274 (1999) 32099-32107
97. Fulop N., Zhang Z., Marchase R.B., and Chatham J.C. Glucosamine cardioprotection in perfused rat heart associated with increased O-Linked N-acetylglucosamine protein modification and altered p38 activation. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H2227-2236
98. Efthymiou C.A., Mocanu M.M., de Belleroche J., Wells D.J., Latchmann D.S., and Yellon D.M. Heat shock protein 27 protects the heart against myocardial infarction. Basic Res. Cardiol. 99 (2004) 392-394
99. Hollander J.M., Martin J.L., Belke D.D., Scott B.T., Swanson E., Krishnamoorthy V., and Dillmann W.H. Overexpression of wild-type heat shock protein 27 and a nonphosphorylatable heat shock protein 27 mutant protects against ischemia/reperfusion injury in a transgenic mouse model. Circulation 110 (2004) 3544-3552
100. Li G., Ali I.S., and Currie R.W. Insulin-induced myocardial protection in isolated ischemic rat hearts requires p38 MAPK phosphorylation of Hsp27. Am. J. Physiol. Heart Circ. Physiol. 294 (2008) H74-H87
101. Ray P.S., Martin J.L., Swanson E.A., Otani H., Dillmann W.H., and Das D.K. Transgene overexpression of alphaB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. Faseb. J. 15 (2001) 393-402
102. Martindale J.J., Wall J.A., Martinez-Longoria D.M., Aryal P., Rockman H.A., Guo Y., Bolli R., and Glembotski C.C. Overexpression of mitogen-activated protein kinase kinase 6 in the heart improves functional recovery from ischemia in vitro and protects against myocardial infarction in vivo. J. Biol. Chem. 280 (2005) 669-676
103. Roquemore E.P., Chevrier M.R., Cotter R.J., and Hart G.W. Dynamic O-GlcNAcylation of the small heat shock protein alpha B-crystallin. Biochemistry 35 (1996) 3578-3586
104. Whelan S.A., and Hart G.W. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation. Circ. Res. 93 (2003) 1047-1058
105. Zhang F., Su K., Yang X., Bowe D.B., Paterson A.J., and Kudlow J.E. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115 (2003) 715-725
106. Brookes P.S., Yoon Y., Robotham J.L., Anders M.W., and Sheu S.S. Calcium, ATP, and ROS: A mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 287 (2004) C817-C833
107. Temsah R.M., Kawabata K., Chapman D., and Dhalla N.S. Preconditioning prevents alterations in cardiac SR gene expression due to ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 282 (2002) H1461-H1466
108. Broad L.M., Braun F.J., Lievremont J.P., Bird G.S., Kurosaki T., and Putney J.W. Role of the phospholipase C-inositol 1,4,5-trisphosphate pathway in calcium release-activated calcium current (Icrac) and capacitative calcium entry. J. Biol. Chem 276 (2001) 15945-15952
109. Putney Jr. J.W., Broad L.M., Braun F.J., Lievremont J.P., and Bird G.S. Mechanisms of capacitative calcium entry. J. Cell Sci. 114 (2001) 2223-2229
110. Trepakova E.S., Csutora P., Hunton D.L., Marchase R.B., Cohen R.A., and Bolotina V.M. Calcium influx factor directly activates store-operated cation channels in vascular smooth muscle cells. J. Biol. Chem. 275 (2000) 26158-26163
111. 2+ entry into mouse skeletal muscle fibres. J. Physiol. (London) 533 (2001) 185-199
112. 2+ entry in skeletal muscle on STIM1 and Orai1. J. Physiol. 586 (2008) 4815-4824
113. 2+ entry in aged skeletal muscle. Aging Cell 7 (2008) 561-568
114. Shin D.M., and Muallem S. Skeletal muscle dressed in SOCs. Nat. Cell Biol. 10 (2008) 639-641
115. Stiber J., Hawkins A., Zhang Z.S., Wang S., Burch J., Graham V., Ward C.C., Seth M., Finch E., Malouf N., Williams R.S., Eu J.P., and Rosenberg P. STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle. Nat. Cell Biol. 10 (2008) 688-697
116. Kim D., and Fu C. Activation of a nonselective cation channel by swelling in atrial cells. J. Memb. Biol. 135 (1993) 27-37
117. Sigurdson W., Ruknudin A., and Sachs F. Calcium imaging of mechanically induced fluxes in tissue-cultured chick heart: role of stretch-activated ion channels. Am. J. Physiol. Heart Circ. Physiol. 262 (1992) H1110-H1115
118. Niedergerke R. Movements of Ca in frog heart ventricles at rest and during contractures. J. Physiol. (London) 167 (1963) 515-550
119. Lamont C., and Eisner D.A. The sarcolemmal mechanisms involved in the control of diastolic intracellular calcium in isolated rat cardiac trabeculae. Pflug. Arch. 432 (1996) 961-969
120. Tominaga M., Matsumori A., Horie M., Yoshida H., and Okada Y. Activation of Ca-permeable cation channels by myocarditis-associated antibody in guinea pig ventricular myocytes. J. Clin. Invest. 91 (1993) 1231-1234
121. Wang S.Y., Clague J.R., and Langer G.A. Increase in calcium leak channel activity by metabolic inhibition or hydrogen peroxide in rat ventricular myocytes and its inhibition by polycation. J. Mol. Cell Cardiol. 27 (1995) 211-222
122. 2+ channels activated by chlorpromazine and free radicals in membrane of human atrial myocytes. J. Mol. Cell Cardiol 30 (1998) 2623-2636
123. Hunton D.L., Lucchesi P.A., Pang Y., Cheng X., Dell'Italia L.J., and Marchase R.B. Capacitative calcium entry contributes to nuclear factor of activated T-cells nuclear translocation and hypertrophy in cardiomyocytes. J. Biol. Chem. 277 (2002) 14266-14273
124. Hunton D.L., Zou L.Y., Pang Y., and Marchase R.B. Adult rat cardiomyocytes exhibit capacitative calcium entry. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H1124-H1132
125. Pang Y., Hunton D.L., Bounelis P., and Marchase R.B. Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes. Diabetes 51 (2002) 3461-3467
126. Ohba T., Watanabe H., Murakami M., Takahashi Y., Iino K., Kuromitsu S., Mori Y., Ono K., Iijima T., and Ito H. Upregulation of TRPC1 in the development of cardiac hypertrophy. J. Mol. Cell Cardiol. 42 (2007) 498-507
127. Nakayama H., Wilkin B.J., Bodi I., and Molkentin J.D. Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. Faseb. J. 20 (2006) 1660-1670
128. 2+ responses to capacitative Ca2+ influx in rat aortic smooth muscle cells. Am. J. Physiol. 269 (1995) C1482-C1488
129. Vemuri S., and Marchase R.B. The inhibition of capacitative calcium entry due to ATP depletion but not due to glucosamine is reversed by staurosporine. J. Biol. Chem. 274 (1999) 20165-20170
130. 2+ elevation in neonatal cardiomyocytes via protein-associated O-GlcNAc. Am. J. Physiol. Cell Physiol. 290 (2006) C57-C65
131. Pang Y., Bounelis P., Chatham J.C., and Marchase R.B. The hexosamine pathway is responsible for the inhibition by diabetes of phenylephrine-induced inotropy. Diabetes 53 (2004) 1074-1081
132. 2+ entry in isolated canine pulmonary arterial smooth muscle cells. J. Physiol. 563 (2005) 409-419
133. 2+ entry pathways activated by store-depletion or hypoxia in canine pulmonary arterial smooth muscle cells. Am. J. Physiol. Cell Physiol. 294 (2008) C313-C323
134. 2+ exchange in hypoxic pulmonary vasoconstriction in rat intrapulmonary arteries. Novartis. Found. Symp. 272 (2006) 259-268 (discussion 268-279)
135. 2+ stores and on electrostatic interactions. Mol. Biol. Cell 20 (2009) 389-399
136. Varnai P., Hunyady L., and Balla T. STIM and Orai: The long-awaited constituents of store-operated calcium entry. Trends. Pharmacol. Sci. 30 (2009) 118-128
137. Cahalan M.D. STIMulating store-operated Ca(2+) entry. Nat. Cell Biol. 11 (2009) 669-677
138. Hart G.W., Housley M.P., and Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446 (2007) 1017-1022
139. Yang X., Su K., Roos M.D., Chang Q., Paterson A.J., and Kudlow J.E. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6611-6616
140. Lim K., and Chang H.I. O-GlcNAc inhibits interaction between Sp1 and Elf-1 transcription factors. Biochem. Biophys. Res. Commun. 380 (2009) 569-574
141. Lim K., and Chang H.I. O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1. FEBS Lett. 583 (2009) 512-520
142. Lamarre-Vincent N., and Hsieh-Wilson L.C. Dynamic glycosylation of the transcription factor CREB: A potential role in gene regulation. J. Am. Chem. Soc. 125 (2003) 6612-6613
143. Laczy B., Hill B.G., Wang K., A.J. P., White C.R., Xing D., Chen Y.-F., Darley-Usmar V., Oparil S., and Chatham J.C. Protein O-GlcNAcylation: A new signaling paradigm for the cardiovascular system. Am. J. Physiol. Heart Circ. Physiolo. 296 (2009) H13-H28
144. 2+ store depletion. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 9301-9306